Trials / Completed
CompletedNCT01464086
LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 107 (actual)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 5 Years – 71 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the diagnostic efficacy of two follow-up schedules for the early detection of cancers in the population under study on cancer incidence at 3 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | whole body MRI | whole body MRI at inclusion, one and two years |
Timeline
- Start date
- 2011-10-27
- Primary completion
- 2017-03-31
- Completion
- 2017-10-09
- First posted
- 2011-11-03
- Last updated
- 2021-02-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01464086. Inclusion in this directory is not an endorsement.